Chicago Equity Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $1.27M | Buy |
+2,605
| New | +$1.27M | 0.13% | 237 |
|
|
2019
Q2 | – | Sell |
-7,170
| Closed | -$2.94M | – | 962 |
|
|
2019
Q1 | $2.94M | Buy |
7,170
+442
| +7% | +$181K | 0.11% | 244 |
|
|
2018
Q4 | $2.51M | Sell |
6,728
-3,945
| -37% | -$1.47M | 0.1% | 285 |
|
|
2018
Q3 | $4.31M | Buy |
10,673
+118
| +1% | +$47.7K | 0.13% | 223 |
|
|
2018
Q2 | $3.64M | Buy |
10,555
+4,460
| +73% | +$1.54M | 0.11% | 271 |
|
|
2018
Q1 | $2.1M | Buy |
6,095
+4,425
| +265% | +$1.52M | 0.07% | 365 |
|
|
2017
Q4 | $628K | Buy |
1,670
+160
| +11% | +$60.2K | 0.02% | 576 |
|
|
2017
Q3 | $675K | Buy |
+1,510
| New | +$675K | 0.02% | 579 |
|
|
2016
Q1 | – | Sell |
-1,270
| Closed | -$689K | – | 646 |
|
|
2015
Q4 | $689K | Buy |
1,270
+365
| +40% | +$198K | 0.02% | 427 |
|
|
2015
Q3 | $421K | Buy |
+905
| New | +$421K | 0.01% | 488 |
|
|
2014
Q1 | – | Sell |
-1,500
| Closed | -$412K | – | 478 |
|
|
2013
Q4 | $412K | Buy |
1,500
+25
| +2% | +$6.87K | 0.01% | 324 |
|
|
2013
Q3 | $461K | Sell |
1,475
-95
| -6% | -$29.7K | 0.01% | 347 |
|
|
2013
Q2 | $353K | Buy |
+1,570
| New | +$353K | 0.01% | 366 |
|